| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2024 |
Carbone G, Bencivenga L, Santoro MA, De Lucia N, Palaia ME, Ercolano E, Scognamiglio F, Edison P, Ferrara N, Vitale DF, Rengo G, Femminella GD. Impact of serum leptin and adiponectin levels on brain infarcts in patients with mild cognitive impairment and Alzheimer's disease: a longitudinal analysis. Frontiers in Endocrinology. 15: 1389014. PMID 38686200 DOI: 10.3389/fendo.2024.1389014 |
0.01 |
|
| 2024 |
Edison P. . Brain Connectivity. 14: 141-143. PMID 38652462 DOI: 10.1089/brain.2024.72792.editorial |
0.01 |
|
| 2024 |
Alagaratnam J, Thornhill JP, Fan Z, Vera JH, Underwood J, Hall R, Searle G, Owen D, Edison P, Fidler S, Winston A. Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) study. Journal of Neurovirology. PMID 38575831 DOI: 10.1007/s13365-024-01200-3 |
0.01 |
|
| 2024 |
Edison P. . Brain Connectivity. 14: 81-83. PMID 38498676 DOI: 10.1089/brain.2024.29060.editorial |
0.01 |
|
| 2024 |
Edison P. . Brain Connectivity. 14: 1-3. PMID 38386375 DOI: 10.1089/brain.2024.29059.editorial |
0.01 |
|
| 2024 |
Hönig M, Altomare D, Caprioglio C, Collij L, Barkhof F, Van Berckel B, Scheltens P, Farrar G, Battle MR, Theis H, Giehl K, Bischof GN, Garibotto V, Molinuevo JLL, Grau-Rivera O, ... ... Edison P, et al. Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease. Neurology. 102: e208053. PMID 38377442 DOI: 10.1212/WNL.0000000000208053 |
0.01 |
|
| 2024 |
Edison P. Astroglial activation: Current concepts and future directions. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38305570 DOI: 10.1002/alz.13678 |
0.01 |
|
| 2024 |
Patel V, Edison P. Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 38290839 DOI: 10.1136/jnnp-2023-332661 |
0.01 |
|
| 2023 |
Edison P. Advancing the Field of Neurology. Brain Connectivity. 13: 575-577. PMID 38149921 DOI: 10.1089/brain.2023.29057.editorial |
0.01 |
|
| 2023 |
Edison P. Advancing the Field of Neurology. Brain Connectivity. 13: 519-520. PMID 37955991 DOI: 10.1089/brain.2023.29056.editorial |
0.01 |
|
| 2023 |
Edison P. Advancing the Field of Neurology . Brain Connectivity. 13: 437. PMID 37782213 DOI: 10.1089/brain.2023.29055.editorial |
0.01 |
|
| 2023 |
Edison P. Advancing the Field of Neurology. Brain Connectivity. 13: 367-369. PMID 37703541 DOI: 10.1089/brain.2023.29053.editorial |
0.01 |
|
| 2023 |
Edison P. Brain Connectivity: Advances in Alzheimer's Disease. Brain Connectivity. 13: 316-318. PMID 37552826 DOI: 10.1089/brain.2023.29052.editorial |
0.01 |
|
| 2023 |
Nowell J, Blunt E, Gupta D, Edison P. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease. Ageing Research Reviews. 101979. PMID 37328112 DOI: 10.1016/j.arr.2023.101979 |
0.01 |
|
| 2023 |
Edison P. Brain Connectivity: . Brain Connectivity. 13: 265. PMID 37267254 DOI: 10.1089/brain.2023.29050.editorial |
0.01 |
|
| 2023 |
Edison P. . Brain Connectivity. 13: 175-177. PMID 37172297 DOI: 10.1089/brain.2023.29048.editorial |
0.01 |
|
| 2023 |
Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, ... ... Edison P, et al. Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial. Jama Neurology. PMID 37155177 DOI: 10.1001/jamaneurol.2023.0997 |
0.01 |
|
| 2023 |
Edison P. Brain Connectivity: A Journal of Clinical Neurology, Neuroscience, & Neuroimaging Advancing the Field of Neurology. Brain Connectivity. 13: 117-119. PMID 37022289 DOI: 10.1089/brain.2023.29047.editorial |
0.01 |
|
| 2023 |
Edison P. Advancing the Field of Neurology. Brain Connectivity. 13: 61-63. PMID 36930159 DOI: 10.1089/brain.2023.29046.editorial |
0.01 |
|
| 2023 |
Fleming B, Edison P, Kenny L. Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management. Bmj (Clinical Research Ed.). 380: e071726. PMID 36921926 DOI: 10.1136/bmj-2022-071726 |
0.01 |
|
| 2023 |
Edison P. Advancing the Field of Neurology. Brain Connectivity. 13: 1-3. PMID 36787414 DOI: 10.1089/brain.2023.29045.editorial |
0.01 |
|
| 2023 |
Crook H, Ramirez A, Hosseini AA, Vavougyios G, Lehmann C, Bruchfeld J, Schneider A, d'Avossa G, Lo Re V, Salmoiraghi A, Mukaetova-Ladinska E, Katshu M, Boneschi FM, Håkansson K, Geerlings M, ... ... Edison P, et al. European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19. Brain Connectivity. PMID 36719785 DOI: 10.1089/brain.2022.0058 |
0.01 |
|
| 2023 |
Caprioglio C, Ribaldi F, Visser LNC, Minguillon C, Collij LE, Grau-Rivera O, Zeyen P, Molinuevo JL, Gispert JD, Garibotto V, Moro C, Walker Z, Edison P, Demonet JF, Barkhof F, et al. Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline. Jama Network Open. 6: e2250921. PMID 36637820 DOI: 10.1001/jamanetworkopen.2022.50921 |
0.01 |
|
| 2022 |
Young M, Crook H, Scott J, Edison P. Covid-19: virology, variants, and vaccines. Bmj Medicine. 1: e000040. PMID 36936563 DOI: 10.1136/bmjmed-2021-000040 |
0.01 |
|
| 2022 |
Edison P. . Brain Connectivity. 12: 847-849. PMID 36520594 DOI: 10.1089/brain.2022.29043.editorial |
0.01 |
|
| 2022 |
Leng F, Hinz R, Gentleman S, Hampshire A, Dani M, Brooks DJ, Edison P. Neuroinflammation is independently associated with brain network dysfunction in Alzheimer's disease. Molecular Psychiatry. PMID 36474000 DOI: 10.1038/s41380-022-01878-z |
0.01 |
|
| 2022 |
Edison P. Advancing the Field of Neurology. Brain Connectivity. 12: 771-773. PMID 36356287 DOI: 10.1089/brain.2022.29041.editorial |
0.01 |
|
| 2022 |
Edison P. : Advancing the Field of Neurology. Brain Connectivity. 12: 683-685. PMID 36265008 DOI: 10.1089/brain.2022.29040.editorial |
0.01 |
|
| 2022 |
Nowell J, Blunt E, Edison P. Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease. Molecular Psychiatry. PMID 36258018 DOI: 10.1038/s41380-022-01792-4 |
0.01 |
|
| 2022 |
de Erausquin GA, Snyder H, Brugha TS, Seshadri S, Carrillo M, Sagar R, Huang Y, Newton C, Tartaglia C, Teunissen C, Håkanson K, Akinyemi R, Prasad K, D'Avossa G, Gonzalez-Aleman G, ... ... Edison P, et al. Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium. Alzheimer's & Dementia (New York, N. Y.). 8: e12348. PMID 36185993 DOI: 10.1002/trc2.12348 |
0.01 |
|
| 2022 |
Edison P. : Advancing the Field of Neurology. Brain Connectivity. 12: 599-601. PMID 36112132 DOI: 10.1089/brain.2022.29039.editorial |
0.01 |
|
| 2022 |
Mohamed MA, Zeng Z, Gennaro M, Lao-Kaim NP, Myers JFM, Calsolaro V, Femminella GD, Tyacke RJ, Martin-Bastida A, Gunn RN, Nutt DJ, Edison P, Piccini P, Roussakis AA. Astrogliosis in aging and Parkinson's disease dementia: a new clinical study with C-BU99008 PET. Brain Communications. 4: fcac199. PMID 36072646 DOI: 10.1093/braincomms/fcac199 |
0.01 |
|
| 2022 |
Pasqualetti G, Thayanandan T, Edison P. Influence of genetic and cardiometabolic risk factors in Alzheimer's disease. Ageing Research Reviews. 81: 101723. PMID 36038112 DOI: 10.1016/j.arr.2022.101723 |
0.01 |
|
| 2022 |
Edison P. . Brain Connectivity. 12: 498-501. PMID 35926197 DOI: 10.1089/brain.2022.29038.editorial |
0.01 |
|
| 2022 |
Edison P. Call for Papers: . Brain Connectivity. 12: 497. PMID 35776548 DOI: 10.1089/brain.2022.29037.cfp |
0.01 |
|
| 2022 |
Loreto F, Fitzgerald A, Golemme M, Gunning S, Win Z, Patel N, Carswell C, Perry R, Kennedy A, Edison P, Malhotra P. Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective Study. Journal of Alzheimer's Disease : Jad. PMID 35754270 DOI: 10.3233/JAD-220170 |
0.01 |
|
| 2022 |
Edison P. : A Journal of Clinical Neurology, Neuroscience, and Neuroimaging. Brain Connectivity. 12: 399-401. PMID 35679178 DOI: 10.1089/brain.2022.29036.ped |
0.01 |
|
| 2022 |
Edison P. : A Journal of Clinical Neurology and Neuroscience. Brain Connectivity. 12: 299-301. PMID 35575589 DOI: 10.1089/brain.2022.29035.ped |
0.01 |
|
| 2022 |
Leng F, Zhan Z, Sun Y, Liu F, Edison P, Sun Y, Wang Z. Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 35491791 DOI: 10.3233/JAD-220102 |
0.01 |
|
| 2022 |
Edison P. A Clinical Neurology and Neuroscience Journal. Brain Connectivity. 12: 207-209. PMID 35451854 DOI: 10.1089/brain.2022.29034.ped |
0.01 |
|
| 2022 |
Edison P. A Journal of Clinical Neurology and Neuroscience. Brain Connectivity. 12: 109-111. PMID 35286220 DOI: 10.1089/brain.2022.29033.ped |
0.01 |
|
| 2022 |
Edison P. Brain Connectivity. Brain Connectivity. PMID 35172103 DOI: 10.1089/brain.2021.29025.cfp6 |
0.01 |
|
| 2022 |
Edison P. Brain Connectivity: A Comprehensive Journal in Clinical Neurology and Neuroscience. Brain Connectivity. 12: 3-5. PMID 35157503 DOI: 10.1089/brain.2021.29032.ped |
0.01 |
|
| 2022 |
Livingston NR, Calsolaro V, Hinz R, Nowell J, Raza S, Gentleman S, Tyacke RJ, Myers J, Venkataraman AV, Perneczky R, Gunn RN, Rabiner EA, Parker CA, Murphy PS, Wren PB, ... ... Edison P, et al. Relationship between astrocyte reactivity, using novel C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals. Molecular Psychiatry. PMID 35125495 DOI: 10.1038/s41380-021-01429-y |
0.01 |
|
| 2022 |
Edison P. Brain Connectivity. Brain Connectivity. PMID 35099262 DOI: 10.1089/brain.2021.29025.cfp5 |
0.01 |
|
| 2021 |
Edison P. Brain Connectivity. Brain Connectivity. 12: 2. PMID 34967681 DOI: 10.1089/brain.2021.29025.cfp4 |
0.01 |
|
| 2021 |
Edison P. COVID-19, Network Dysfunction and Neurodegeneration. Brain Connectivity. 11: 785-787. PMID 34889649 DOI: 10.1089/brain.2021.29030.ped |
0.01 |
|
| 2021 |
Edison P. : Evaluating Neurological Complications in COVID-19. Brain Connectivity. 11: 692-694. PMID 34762501 DOI: 10.1089/brain.2021.29028.ped |
0.01 |
|
| 2021 |
Edison P. Brain Connectivity. Brain Connectivity. PMID 34694930 DOI: 10.1089/brain.2021.29025.cfp3 |
0.01 |
|
| 2021 |
Edison P. Advancing Neuroscience and Neuroimaging. Brain Connectivity. 11: 596-598. PMID 34665677 DOI: 10.1089/brain.2021.29027.ped |
0.01 |
|
| 2021 |
Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, Savard M, Lussier FZ, Tissot C, Karikari TK, Ottoy J, Mathotaarachchi S, Stevenson J, Massarweh G, Schöll M, ... ... Edison P, et al. Publisher Correction: Microglial activation and tau propagate jointly across Braak stages. Nature Medicine. PMID 34654920 DOI: 10.1038/s41591-021-01568-3 |
0.01 |
|
| 2021 |
Edison P. : Advances in Neuroimaging to Investigate COVID-19. Brain Connectivity. 11: 502-504. PMID 34529506 DOI: 10.1089/brain.2021.29026.ped |
0.01 |
|
| 2021 |
Edison P. Brain Connectivity. Brain Connectivity. PMID 34463155 DOI: 10.1089/brain.2021.29025.cfp2 |
0.01 |
|
| 2021 |
Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, Savard M, Lussier FZ, Tissot C, Karikari TK, Ottoy J, Mathotaarachchi S, Stevenson J, Massarweh G, Schöll M, ... ... Edison P, et al. Microglial activation and tau propagate jointly across Braak stages. Nature Medicine. PMID 34446931 DOI: 10.1038/s41591-021-01456-w |
0.01 |
|
| 2021 |
Edison P. Brain Connectivity. Brain Connectivity. PMID 34402685 DOI: 10.1089/brain.2021.29025.cfp |
0.01 |
|
| 2021 |
Edison P. : Neuronal Damage in COVID-19. Brain Connectivity. 11: 405-407. PMID 34379495 DOI: 10.1089/brain.2021.29024.ped |
0.01 |
|
| 2021 |
Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. Bmj (Clinical Research Ed.). 374: n1648. PMID 34312178 DOI: 10.1136/bmj.n1648 |
0.01 |
|
| 2021 |
Mallon DH, Malhotra P, Naik M, Edison P, Perry R, Carswell C, Win Z. The role of amyloid PET in patient selection for extra-ventricular shunt insertion for the treatment of idiopathic normal pressure hydrocephalus: A pooled analysis. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 90: 325-331. PMID 34275571 DOI: 10.1016/j.jocn.2021.06.017 |
0.01 |
|
| 2021 |
Calsolaro V, Matthews PM, Donat CK, Livingston NR, Femminella GD, Guedes SS, Myers J, Fan Z, Tyacke RJ, Venkataraman AV, Perneczky R, Gunn R, Rabiner EA, Gentleman S, Parker CA, ... ... Edison P, et al. Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using C-BU99008 PET and its relationship with amyloid load. Molecular Psychiatry. PMID 34267329 DOI: 10.1038/s41380-021-01193-z |
0.01 |
|
| 2021 |
Alagaratnam J, von Widekind S, De Francesco D, Underwood J, Edison P, Winston A, Zetterberg H, Fidler S. Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis. Bmj Neurology Open. 3: e000143. PMID 34223154 DOI: 10.1136/bmjno-2021-000143 |
0.01 |
|
| 2021 |
Edison P. and Neurological Sequalae in COVID-19. Brain Connectivity. 11: 331-332. PMID 34100631 DOI: 10.1089/brain.2021.29023.ped |
0.01 |
|
| 2021 |
Edison P. Microglial activation and blood-brain barrier leakage: chicken and egg? Brain : a Journal of Neurology. PMID 34028556 DOI: 10.1093/brain/awab149 |
0.01 |
|
| 2021 |
Edison P. and COVID-19. Brain Connectivity. 11: 251-252. PMID 33974441 DOI: 10.1089/brain.2021.29022.ped |
0.01 |
|
| 2021 |
Edison P. and Alzheimer's Disease. Brain Connectivity. 11: 157-158. PMID 33861627 DOI: 10.1089/brain.2021.29021.ped |
0.01 |
|
| 2021 |
Edison P. Neurocognitive Involvement in COVID-19. Brain Connectivity. 11: 73-74. PMID 33734904 DOI: 10.1089/brain.2021.29020.ped |
0.01 |
|
| 2021 |
Kobro-Flatmoen A, Lagartos-Donate MJ, Aman Y, Edison P, Witter MP, Fang EF. Re-emphasizing early Alzheimer's disease pathology starting in select entorhinal neurons, with a special focus on mitophagy. Ageing Research Reviews. 101307. PMID 33621703 DOI: 10.1016/j.arr.2021.101307 |
0.01 |
|
| 2021 |
Edison P. Advancing the Field of Neuroscience in the Era of COVID-19. Brain Connectivity. 11: 1-2. PMID 33616453 DOI: 10.1089/brain.2021.29019.ped |
0.01 |
|
| 2021 |
Femminella GD, Livingston NR, Raza S, van der Doef T, Frangou E, Love S, Busza G, Calsolaro V, Carver S, Holmes C, Ritchie CW, Lawrence RM, McFarlane B, Tadros G, Ridha BH, ... ... Edison P, et al. Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects? Alzheimer's Research & Therapy. 13: 47. PMID 33597002 DOI: 10.1186/s13195-021-00784-w |
0.01 |
|
| 2020 |
Edison P. in Neuronal Integrity. Brain Connectivity. 10: 533-534. PMID 33332221 DOI: 10.1089/brain.2020.29016.ped |
0.01 |
|
| 2020 |
Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nature Reviews. Neurology. PMID 33318676 DOI: 10.1038/s41582-020-00435-y |
0.01 |
|
| 2020 |
Femminella GD, Harold D, Scott J, Williams J, Edison P. The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 33216025 DOI: 10.3233/JAD-200578 |
0.01 |
|
| 2020 |
Edison P. in Neurodegenerative Diseases. Brain Connectivity. 10: 465-466. PMID 33210959 DOI: 10.1089/brain.2020.29015.ped |
0.01 |
|
| 2020 |
Edison P. in the Era of Artificial Intelligence. Brain Connectivity. 10: 397-398. PMID 33090928 DOI: 10.1089/brain.2020.29014.ped |
0.01 |
|
| 2020 |
Edison P. and Cognitive Impairment. Brain Connectivity. 10: 329-330. PMID 32940578 DOI: 10.1089/brain.2020.29013.ped |
0.01 |
|
| 2020 |
Edison P. Brain Connectivity Modalities in Alzheimer's Disease. Brain Connectivity. 10: 253. PMID 32813577 DOI: 10.1089/brain.2020.29010.cfp2 |
0.01 |
|
| 2020 |
Edison P. Brain Connectivity: Advances in Neurodegenerative Diseases. Brain Connectivity. 10: 251-252. PMID 32813576 DOI: 10.1089/brain.2020.29012.ped |
0.01 |
|
| 2020 |
Edison P. Neuroinflammation, microglial activation, and glucose metabolism in neurodegenerative diseases. International Review of Neurobiology. 154: 325-344. PMID 32739010 DOI: 10.1016/bs.irn.2020.03.017 |
0.01 |
|
| 2020 |
Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, ... ... Edison P, et al. Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials. 21: 660. PMID 32684162 DOI: 10.1186/S13063-020-04608-4 |
0.01 |
|
| 2020 |
Edison P. Brain Connectivity: Disrupted Structural and Functional Connectivity-Cause or Effect? Brain Connectivity. 10: 200-201. PMID 32573281 DOI: 10.1089/brain.2020.29011.ped |
0.01 |
|
| 2020 |
Edison P. Brain Connectivity Modalities in Alzheimer's Disease. Brain Connectivity. 10: 199. PMID 32573280 DOI: 10.1089/brain.2020.29010.cfp |
0.01 |
|
| 2020 |
Edison P. A Bidirectional Involvement of Structural Connectivity and Pathological Substrates in Neurodegeneration. Brain Connectivity. 10: 155-156. PMID 32407211 DOI: 10.1089/brain.2020.29009.ped |
0.01 |
|
| 2020 |
Edison P. Structural and Functional Neuronal Integrity and Its Relationship with Pathological Substrates. Brain Connectivity. 10: 106-107. PMID 32319829 DOI: 10.1089/brain.2020.29008.ped |
0.01 |
|
| 2020 |
Edison P. The Invisible Enemy That Will Change the World Forever. Brain Connectivity. 10: 105. PMID 32255664 DOI: 10.1089/brain.2020.29007.ped |
0.01 |
|
| 2020 |
Edison P. : Neuronal Integrity and Its Relationship with Pathological Substrates. Brain Connectivity. 10: 51-52. PMID 32195609 DOI: 10.1089/brain.2020.29006.ped |
0.01 |
|
| 2020 |
Edison P. : Structural Integrity and Brain Function. Brain Connectivity. 10: 1-2. PMID 32073899 DOI: 10.1089/brain.2020.29005.ped |
0.01 |
|
| 2020 |
Edison P, Raza S, Femminella GD, Blunt EG, Carver S, Livingston NR, Nowell J, Holmes C, Ritchie CW, Lawrence RM, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, et al. Relationship between spectral analysis, SUV and SUV Pons ratio as a measure of cerebral glucose metabolic rate in Alzheimer's disease Alzheimer's & Dementia. 16. DOI: 10.1002/alz.046068 |
0.01 |
|
| 2020 |
Kleniuk J, Edison P. Association of cardiovascular risk and sex with cortical tau deposition in cognitively normal and at‐risk Alzheimer’s subjects Alzheimer's & Dementia. 16. DOI: 10.1002/alz.046050 |
0.01 |
|
| 2020 |
Leng F, Hinz R, Dani M, Hampshire A, Gentleman S, Brooks DJ, Edison P. Tau formation is associated with microglial activation in more widespread cortical areas than is amyloid deposition Alzheimer's & Dementia. 16. DOI: 10.1002/alz.046045 |
0.01 |
|
| 2020 |
Edison P, Femminella GD, Nowell J, Raza S, Livingston NR, Blunt EG, Carver S, Holmes C, Ritchie CW, Lawrence RM, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, et al. Assessing the relationship between cognitive dysfunction and brain atrophy in Alzheimer's disease Alzheimer's & Dementia. 16. DOI: 10.1002/alz.046004 |
0.01 |
|
| 2020 |
Edison P, Femminella GD, Livingston NR, Raza S, Nowell J, Carver S, Holmes C, Blunt EG, Lawrence RM, McFarlane B, Tadros G, Ritchie CW, Ridha BH, Bannister C, Walker Z, et al. Influence of cerebral glucose metabolic rate on cognitive function in Alzheimer's subjects Alzheimer's & Dementia. 16. DOI: 10.1002/alz.045899 |
0.01 |
|
| 2020 |
Calsolaro V, Hinz R, Femminella GD, Pasqualetti G, Buckley CJ, Gentleman S, Brooks DJ, Edison P. Microglial activation evaluated using flutriciclamide (
11
F‐GE180) in subjects with cognitive impairment Alzheimer's & Dementia. 16. DOI: 10.1002/alz.045465 |
0.01 |
|
| 2020 |
Femminella GD, van der Doef T, Carver S, Holmes C, Ritchie CW, Lawrence RM, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood B, Prasanna A, ... ... Edison P, et al. Behavioural symptoms in Alzheimer’s disease are associated with white matter lesions (WML) volume and are independent of atrophy and hypometabolism Alzheimer's & Dementia. 16. DOI: 10.1002/alz.045223 |
0.01 |
|
| 2020 |
Leng F, Hinz R, Dani M, Hampshire A, Gentleman S, Brooks DJ, Edison P. Influence of microglial activation on structural and functional connectivity in mild cognitive impairment subjects Alzheimer's & Dementia. 16. DOI: 10.1002/alz.042990 |
0.01 |
|
| 2020 |
Rosa‐Neto P, Pascoal TA, Benedet AL, Kang MS, Savard M, Mathotaarachchi S, Edison P, Chamoun M, Stevenson J, Therriault J, Massarweh G, Soucy J, Gauthier S. Neuroinflammation imposes vulnerability to tau propagation Alzheimer's & Dementia. 16. DOI: 10.1002/alz.039814 |
0.01 |
|
| 2020 |
Maskery M, Gengler S, Goulding EM, Melchiorsen JU, Rosenkilde MM, Edison P, Holscher C. The dual GLP‐1/GIP receptor agonist DA4‐JC shows superior protective properties in the APP/PS1 mouse model of Alzheimer’s disease Alzheimer's & Dementia. 16. DOI: 10.1002/alz.039220 |
0.01 |
|
| 2019 |
Edison P. : The Basis of Neuronal Integrity. Brain Connectivity. 9: 743-744. PMID 31851549 DOI: 10.1089/brain.2019.29004.ped |
0.01 |
|
| 2019 |
Edison P. A Note from the Editor-in-Chief. Brain Connectivity. 9: 661. PMID 31725333 DOI: 10.1089/brain.2019.29003.ped |
0.01 |
|
| 2019 |
Edison P. A Note from Our New Editor-in-Chief. Brain Connectivity. 9: 593. PMID 31622125 DOI: 10.1089/brain.2019.29002.ped |
0.01 |
|
| 2019 |
Dani M, Wood M, Mizoguchi R, Fan Z, Edginton T, Hinz R, Win Z, Brooks DJ, Edison P. Tau Aggregation Correlates with Amyloid Deposition in Both Mild Cognitive Impairment and Alzheimer's Disease Subjects. Journal of Alzheimer's Disease : Jad. PMID 31256120 DOI: 10.3233/Jad-181168 |
0.01 |
|
| 2019 |
Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31230910 DOI: 10.1016/J.Jalz.2019.02.004 |
0.01 |
|
| 2019 |
Wang YT, Edison P. Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography. Current Neurology and Neuroscience Reports. 19: 45. PMID 31172290 DOI: 10.1007/s11910-019-0962-7 |
0.01 |
|
| 2019 |
Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, ... ... Edison P, et al. Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials. 20: 191. PMID 30944040 DOI: 10.1186/S13063-019-3259-X |
0.01 |
|
| 2019 |
Schubert JJ, Veronese M, Marchitelli L, Bodini B, Tonietto M, Stankoff B, Brooks DJ, Bertoldo A, Edison P, Turkheimer F. Dynamic C-PiB PET shows cerebrospinal fluid flow alterations in Alzheimer's disease and multiple sclerosis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30850505 DOI: 10.2967/Jnumed.118.223834 |
0.01 |
|
| 2019 |
Femminella GD, Dani M, Wood M, Fan Z, Calsolaro V, Atkinson R, Edginton T, Hinz R, Brooks DJ, Edison P. Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume. Neurology. PMID 30796139 DOI: 10.1212/Wnl.0000000000007133 |
0.01 |
|
| 2019 |
Calsolaro V, Hampshire A, Femminella GD, Brooks DJ, Edison P. P4-325: RELATIONSHIP BETWEEN MICROGLIAL ACTIVATION MEASURED BY FLUTRICICLAMIDE AND MICROSTRUCTURAL ALTERATION IN ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT SUBJECTS Alzheimer's & Dementia. 15: P1419-P1420. DOI: 10.1016/J.Jalz.2019.06.3995 |
0.01 |
|
| 2019 |
Leng F, Edison P. P4-318: NEUROIMAGING BIOMARKERS TO PREDICT SHORT-TERM COGNITIVE DECLINE IN MCI PATIENTS Alzheimer's & Dementia. 15: P1414-P1415. DOI: 10.1016/j.jalz.2019.06.3988 |
0.01 |
|
| 2019 |
Femminella GD, Wang Y, Doef Tvd, Frangou E, Love S, Calsolaro V, Carver S, Holmes C, Ritchie CW, Lawrence RM, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, ... ... Edison P, et al. P3-328: Does Insulin Resistance Influence White Matter Lesions In Non-Diabetic Ad Subjects? Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3360 |
0.01 |
|
| 2019 |
van der Thiel M, Femminella GD, Harold D, Scott J, Williams J, Edison P. P3-128: THE INFLUENCE OF IMMUNE, ENDOCYTOTIC AND LIPID METABOLISM GENES ON CYTOKINES AND GLUCOSE METABOLISM IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT Alzheimer's & Dementia. 15: P980-P980. DOI: 10.1016/j.jalz.2019.06.3156 |
0.01 |
|
| 2019 |
Calsolaro V, Femminella GD, Buckley C, Turkheimer F, Gentleman S, Hinz R, Brooks DJ, Edison P. P2-400: Microglial Activation Detected By Novel Tspo Tracer Flutriciclamide ([11Fge180]) In Ad And Mci Subjects Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2807 |
0.01 |
|
| 2019 |
Femminella GD, Doef Tvd, Wang Y, Frangou E, Love S, Calsolaro V, Carver S, Holmes C, Ritchie CW, Lawrence RM, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, ... ... Edison P, et al. P2-358: Insulin Resistance Influences Hippocampal Glucose Metabolism Rather Than Hippocampal Volume In Non-Diabetic Alzheimer'S Disease Patients Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2765 |
0.01 |
|
| 2018 |
Li X, Wang H, Long J, Pan G, He T, Anichtchik O, Belshaw R, Albani D, Edison P, Green EK, Scott J. Systematic Analysis and Biomarker Study for Alzheimer's Disease. Scientific Reports. 8: 17394. PMID 30478411 DOI: 10.1038/s41598-018-35789-3 |
0.01 |
|
| 2018 |
Edison P, Donat CK, Sastre M. Imaging of Glial Activation in Alzheimer's Disease. Frontiers in Neurology. 9: 625. PMID 30131755 DOI: 10.3389/fneur.2018.00625 |
0.01 |
|
| 2018 |
Dani M, Wood M, Mizoguchi R, Fan Z, Walker Z, Morgan R, Hinz R, Biju M, Kuruvilla T, Brooks DJ, Edison P. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease. Brain : a Journal of Neurology. PMID 30052812 DOI: 10.1093/Brain/Awy188 |
0.01 |
|
| 2018 |
Femminella GD, Taylor-Davies G, Scott J, Edison P. Do Cardiometabolic Risk Factors Influence Amyloid, Tau, and Neuronal Function in APOE4 Carriers and Non-Carriers in Alzheimer's Disease Trajectory? Journal of Alzheimer's Disease : Jad. PMID 29966204 DOI: 10.3233/JAD-1803656 |
0.01 |
|
| 2018 |
Edison P, Brooks DJ. Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET. Journal of Alzheimer's Disease : Jad. PMID 29865053 DOI: 10.3233/Jad-179929 |
0.01 |
|
| 2018 |
Donat CK, Mirzaei N, Tang SP, Edison P, Sastre M. Erratum to: Imaging of Microglial Activation in Alzheimer's Disease by [C]PBR28 PET. Methods in Molecular Biology (Clifton, N.J.). 1750: E1. PMID 29696592 DOI: 10.1007/978-1-4939-7704-8_26 |
0.01 |
|
| 2018 |
Fan Z, Dani M, Femminella GD, Wood M, Calsolaro V, Veronese M, Turkheimer F, Gentleman S, Brooks DJ, Hinz R, Edison P. Parametric mapping using spectral analysis forC-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29523926 DOI: 10.1007/S00259-018-3984-5 |
0.01 |
|
| 2018 |
Donat CK, Mirzaei N, Tang SP, Edison P, Sastre M. Imaging of Microglial Activation in Alzheimer's Disease by [C]PBR28 PET. Methods in Molecular Biology (Clifton, N.J.). 1750: 323-339. PMID 29512083 DOI: 10.1007/978-1-4939-7704-8_22 |
0.01 |
|
| 2018 |
Calsolaro V, Fan Z, Veronese M, Femminella GD, Pasqualetti G, Trigg W, Buckley CJ, Turkheimer F, Gentleman S, Hinz R, Brooks DJ, Edison P. P1-475: Novel Third Generation Microglial Marker Flutriciclamide ([18F]Ge180) In Alzheimer'S Disease And Mild Cognitive Impairment Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.485 |
0.01 |
|
| 2018 |
Fan Z, Calsolaro V, Mayers J, Tyacke R, Venkataraman A, Femminella GD, Perneczky R, Gunn RN, Rabiner EA, Matthews PM, Nutt D, Edison P. O5-01-05: Relationship Between Astrocyte Activation Using [11C]Bu99008 Pet, Glucose Metabolism And Amyloid In Alzheimer'S Disease: A Dementia Platform Uk Experimental Medicine Study Alzheimers & Dementia. 14: 1640. DOI: 10.1016/J.Jalz.2018.06.2999 |
0.01 |
|
| 2018 |
Femminella GD, Fan Z, Frangou E, Love S, Calsolaro V, Holmes C, Ritchie CW, Lawrence RM, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, ... ... Edison P, et al. P3-225: Peripheral Insulin Resistance Does Not Correlate With Cerebral Glucose Metabolic Rate In Non-Diabetic Alzheimer'S Patients Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1584 |
0.01 |
|
| 2018 |
Calsolaro V, Mayers J, Fan Z, Tyacke R, Venkataraman A, Femminella GD, Perneczky R, Gunn RN, Rabiner EA, Matthews PM, Nutt D, Edison P. P2-381: Evaluation Of Novel Astrocyte Marker [11C]Bu99008 Pet In Alzheimer'S Disease: A Dementia Platform U.K. Experimental Medicine Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1072 |
0.01 |
|
| 2017 |
Femminella GD, Bencivenga L, Petraglia L, Visaggi L, Gioia L, Grieco FV, de Lucia C, Komici K, Corbi G, Edison P, Rengo G, Ferrara N. Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives. Journal of Diabetes Research. 2017: 7420796. PMID 28656154 DOI: 10.1155/2017/7420796 |
0.01 |
|
| 2017 |
Parbo P, Ismail R, Hansen KV, Amidi A, Mårup FH, Gottrup H, Brændgaard H, Eriksson BO, Eskildsen SF, Lund TE, Tietze A, Edison P, Pavese N, Stokholm MG, Borghammer P, et al. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease. Brain : a Journal of Neurology. PMID 28575151 DOI: 10.1093/Brain/Awx120 |
0.01 |
|
| 2017 |
Dani M, Brooks DJ, Edison P. Suspected Non Alzheimer's Pathology - Is it non-Alzheimer's or non-Amyloid? Ageing Research Reviews. PMID 28235659 DOI: 10.1016/J.Arr.2017.02.003 |
0.01 |
|
| 2017 |
Fan Z, Brooks DJ, Okello A, Edison P. An early and late peak in microglial activation in Alzheimer's disease trajectory. Brain : a Journal of Neurology. PMID 28122877 DOI: 10.1093/Brain/Aww349 |
0.01 |
|
| 2017 |
Daniela Femminella G, Taylor‐Davies G, Scott J, Edison P. [O4–01–05]: CARDIOMETABOLIC RISK PREDICTS BIOMARKER PROGRESSION IN ALZHEIMER's DISEASE TRAJECTORY Alzheimer's & Dementia. 13. DOI: 10.1016/j.jalz.2017.07.421 |
0.01 |
|
| 2017 |
Calsolaro V, Fan Z, Femminella GD, Veronese M, Pasqualetti G, Trigg W, Turkheimer F, Gentleman S, Brooks DJ, Hinz R, Edison P, Buckley CJ. Microglial Activation In Alzheimer’S Disease Detected By Novel Third Generation Translocator Protein Tracer Flutriciclamide ([18F]Ge180) Alzheimers & Dementia. 13: 922. DOI: 10.1016/J.Jalz.2017.07.355 |
0.01 |
|
| 2017 |
Femminella GD, Dani M, Wood M, Fan Z, Calsolaro V, Mizoguchi R, Atkinson RA, Edginton T, Waldman A, Hinz R, Brooks DJ, Edison P. Microglial Activation Is Associated With Higher Grey Matter Density And Hippocampal Volume In Mci Subjects Alzheimers & Dementia. 13: 921. DOI: 10.1016/J.Jalz.2017.07.352 |
0.01 |
|
| 2017 |
Dani M, Fan Z, Wood M, Mizoguchi R, Morgan R, Walker Z, Femminella GD, Calsolaro V, Brooks DJ, Edison P. Amyloid Deposition, Tau Aggregation And Microglial Activation Correlate With Vascular Burden In Vivo In Alzheimer'S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.848 |
0.01 |
|
| 2017 |
Calsolaro V, Daniela Femminella G, Fan Z, Dani M, Kozlowski K, Aboagye E, Edison P. [P4–221]: EVALUATION OF CASPASE‐3 ACTIVATION IN AN ALZHEIMER's DISEASE POPULATION USING [
18
F]ICMT‐11 PET/CT Alzheimer's & Dementia. 13. DOI: 10.1016/j.jalz.2017.06.2089 |
0.01 |
|
| 2017 |
Dani M, Wood M, Mizoguchi R, Fan Z, Brooks DJ, Edison P. Different Modelling Approaches For Tau Tracer 18 F-Av1451 In Mild Cognitive Impairment And Alzheimer'S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.197 |
0.01 |
|
| 2017 |
Fan Z, Dani M, Daniela Femminella G, Calsolaro V, Veronese M, Turkheimer F, Gentleman S, Hinz R, Edison P. [P1–124]: REGIONAL KINETIC MODELLING APPLICATION FOR TSPO PET TRACER [11C]PBR28 Alzheimer's & Dementia. 13. DOI: 10.1016/j.jalz.2017.06.191 |
0.01 |
|
| 2017 |
Fan Z, Dani M, Femminella GD, Calsolaro V, Veronese M, Turkheimer F, Brooks DJ, Gentleman S, Hinz R, Edison P. Strategies To Develop Parametric Maps For Tspo Pet Tracer [11C]-Pbr28 In Patients With Mild Cognitive Impairment Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.190 |
0.01 |
|
| 2017 |
Edison P, Mayers J, Calsolaro V, Fan Z, Turton S, Venkataraman A, Femminella GD, Perneczky R, Gunn RN, Rabiner EA, Matthews PM, Tyacke R, Nutt D. Dementia Platform U.K. Experimental Medicine: Human In Vivo Astroglial Activation In Early Alzheimer’S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1539 |
0.01 |
|
| 2016 |
Calsolaro V, Edison P. Alterations in glucose metabolism in Alzheimer's disease. Recent Patents On Endocrine, Metabolic & Immune Drug Discovery. PMID 27306508 |
0.01 |
|
| 2016 |
Fan Z, Calsolaro V, Atkinson RÁ, Femminella GD, Waldman A, Buckley C, Trigg W, Brooks DJ, Hinz R, Edison P. Flutriciclamide (18F-GE180) PET: first in human PET study of novel 3rd generation in vivo marker of human translator protein. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27261523 DOI: 10.2967/Jnumed.115.169078 |
0.01 |
|
| 2016 |
Calsolaro V, Edison P. Neuroinflammation in Alzheimer's disease: Current evidence and future directions. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27179961 DOI: 10.1016/j.jalz.2016.02.010 |
0.01 |
|
| 2016 |
D Femminella G, Ninan S, Atkinson R, Fan Z, J Brooks D, Edison P. Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia? Journal of Alzheimer's Disease : Jad. PMID 27060942 DOI: 10.3233/Jad-150827 |
0.01 |
|
| 2016 |
Scott G, Ramlackhansingh AF, Edison P, Hellyer P, Cole J, Veronese M, Leech R, Greenwood RJ, Turkheimer FE, Gentleman SM, Heckemann RA, Matthews PM, Brooks DJ, Sharp DJ. Amyloid pathology and axonal injury after brain trauma. Neurology. PMID 26843562 DOI: 10.1212/Wnl.0000000000002413 |
0.01 |
|
| 2016 |
Dani M, Edison P, Brooks DJ. Imaging biomarkers in tauopathies. Parkinsonism & Related Disorders. 22: S26-8. PMID 26299160 DOI: 10.1016/J.Parkreldis.2015.08.011 |
0.01 |
|
| 2016 |
Dani M, Edison P, Brooks DJ. Imaging biomarkers in tauopathies Parkinsonism and Related Disorders. 22: S26-S28. DOI: 10.1016/j.parkreldis.2015.08.011 |
0.01 |
|
| 2016 |
Fan Z, Edison P, Atkinson R, Femminella GD, Calsolaro V, Waldman A, Buckley CJ, Trigg W, Brooks DJ, Hinz R. Flutriciclamide ([18F]Ge180) Pet: First In Human Pet Study Of Novel In Vivo Marker Of Human Translator Protein Alzheimers & Dementia. 12: 397. DOI: 10.1016/J.Jalz.2016.06.748 |
0.01 |
|
| 2016 |
Femminella GD, Dani M, Fan Z, Calsolaro V, Atkinson R, Waldman A, Brooks DJ, Edison P, Wood M. Does Neuroinflammation Predate Amyloid Formation In Subjects At Risk For Alzheimer’S Disease? Alzheimers & Dementia. 12: 283. DOI: 10.1016/J.Jalz.2016.06.515 |
0.01 |
|
| 2016 |
Calsolaro V, Ashraf A, Fan Z, Brooks DJ, Edison P. Increased [11C](R)Pk11195-Pet And Attenuated Cerebral Glucose Metabolism: A Common Theme In Neurodegenerative Diseases? Alzheimers & Dementia. 12: 1085. DOI: 10.1016/J.Jalz.2016.06.2267 |
0.01 |
|
| 2016 |
Fan Z, Brooks DJ, Okello A, Edison P. An Early And Late Peak In Microglial Activation In Alzheimer’S Disease Trajectory: A Longitudinal Pet Study Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1033 |
0.01 |
|
| 2016 |
Dani M, Brooks DJ, Edison P. Tau imaging in neurodegenerative diseases European Journal of Nuclear Medicine and Molecular Imaging. 43: 1139-1150. DOI: 10.1007/S00259-015-3231-2 |
0.01 |
|
| 2015 |
Calsolaro V, Edison P. Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases. Cns Drugs. 29: 1023-39. PMID 26666230 DOI: 10.1007/s40263-015-0301-8 |
0.01 |
|
| 2015 |
Fan Z, Okello AA, Brooks DJ, Edison P. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease. Brain : a Journal of Neurology. PMID 26510952 DOI: 10.1093/Brain/Awv288 |
0.01 |
|
| 2015 |
Fan Z, Harold D, Pasqualetti G, Williams J, Brooks DJ, Edison P. Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 707-13. PMID 25840980 DOI: 10.2967/Jnumed.114.149443 |
0.01 |
|
| 2015 |
Pasqualetti G, Brooks DJ, Edison P. The role of neuroinflammation in dementias. Current Neurology and Neuroscience Reports. 15: 17. PMID 25716012 DOI: 10.1007/S11910-015-0531-7 |
0.01 |
|
| 2015 |
Femminella GD, Kenny LM, Sinha A, Amlani S, Edison P. Carcinoid-associated encephalopathy. Journal of Clinical Gastroenterology. 49: 353-4. PMID 25518006 DOI: 10.1097/MCG.0000000000000272 |
0.01 |
|
| 2015 |
Varley J, Brooks DJ, Edison P. Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 1110-20. PMID 25449529 DOI: 10.1016/J.Jalz.2014.08.105 |
0.01 |
|
| 2015 |
Fan Z, Aman Y, Ahmed I, Chetelat G, Landeau B, Ray Chaudhuri K, Brooks DJ, Edison P. Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 608-621.e7. PMID 25239737 DOI: 10.1016/J.Jalz.2014.06.016 |
0.01 |
|
| 2015 |
Femminella GD, Fan Z, Atkinson R, Brooks DJ, Edison P. Glial activation influence on hippocampal volume and glucose metabolism in Alzheimer's disease and pdd Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.036 |
0.01 |
|
| 2015 |
Femminella GD, Fan Z, Wietlicka E, Edison P. P2‐128: Amyloid deposition, glucose metabolism, hippocampal volume, and cognitive decline in mild cognitive impairment: A longitudinal PET study Alzheimer's & Dementia. 11. DOI: 10.1016/j.jalz.2015.06.666 |
0.01 |
|
| 2015 |
Calsolaro V, Fan Z, Brooks DJ, Edison P. Role of neuroinflammation in Alzheimer’s and parkinson’s disease: [11C]PK11195 PET study Alzheimers & Dementia. 11: 792. DOI: 10.1016/J.Jalz.2015.06.1770 |
0.01 |
|
| 2014 |
Femminella GD, Edison P. Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S55-61. PMID 24529526 DOI: 10.1016/j.jalz.2013.12.012 |
0.01 |
|
| 2014 |
Matthews PM, Edison P, Geraghty OC, Johnson MR. The emerging agenda of stratified medicine in neurology. Nature Reviews. Neurology. 10: 15-26. PMID 24323053 DOI: 10.1038/nrneurol.2013.245 |
0.01 |
|
| 2014 |
Femminella GD, Edison P. The therapeutic potential of glucagon-like peptide-1 analogs in the treatment of Alzheimer’s disease Clinical Investigation. 4: 201-203. DOI: 10.4155/CLI.14.12 |
0.01 |
|
| 2014 |
Pasqualetti G, Harris R, Rinne J, Fan Z, Hinz R, Brooks DJ, Edison P. Does cerebral glucose metabolism and blood flow dissociate in early stages of Alzheimer's Disease? Alzheimers & Dementia. 10: 536. DOI: 10.1016/J.Jalz.2014.05.855 |
0.01 |
|
| 2014 |
Femminella GD, Ninan S, Varley J, Atkinson RA, Fan Z, Brooks DJ, Edison P. Influence Of Microglial Activation On Hippocampal Atrophy In Alzheimer'S And Parkinson’S Disease Dementia Alzheimers & Dementia. 10: 830. DOI: 10.1016/J.Jalz.2014.05.1639 |
0.01 |
|
| 2014 |
Ashraf A, Fan Z, Brooks DJ, Edison P. Cortical hypermetabolism in MCI subjects: a compensatory mechanism? European Journal of Nuclear Medicine and Molecular Imaging. 42: 447-458. DOI: 10.1007/s00259-014-2919-z |
0.01 |
|
| 2013 |
Ikoma Y, Edison P, Ramlackhansingh A, Brooks DJ, Turkheimer FE. Reference region automatic extraction in dynamic [(11)C]PIB. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1725-31. PMID 23921900 DOI: 10.1038/Jcbfm.2013.133 |
0.01 |
|
| 2013 |
Edison P, Ahmed I, Fan Z, Hinz R, Gelosa G, Ray Chaudhuri K, Walker Z, Turkheimer FE, Brooks DJ. Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 938-49. PMID 23303049 DOI: 10.1038/Npp.2012.255 |
0.01 |
|
| 2013 |
Edison P, Carter SF, Rinne JO, Gelosa G, Herholz K, Nordberg A, Brooks DJ, Hinz R. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. Neuroimage. 70: 423-33. PMID 23261639 DOI: 10.1016/J.Neuroimage.2012.12.014 |
0.01 |
|
| 2013 |
Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, Långström B, Scheinin N, Karrasch M, Någren K, Grimmer T, Miederer I, Edison P, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 40: 104-14. PMID 22961445 DOI: 10.1007/S00259-012-2237-2 |
0.01 |
|
| 2013 |
McMillan A, Paniccia L, Glasser M, Edison P, Simonds A, Morrell M. S2 The impact of continuous positive airway pressure (CPAP) therapy on cognitive function in older people with sleep disordered breathing (SDB) and co morbidity Thorax. 68: A4.2-A4. DOI: 10.1136/thoraxjnl-2013-204457.8 |
0.01 |
|
| 2013 |
Ashraf A, Mehta P, Edison P. Amyloid imaging in dementia Reviews in Clinical Gerontology. 23: 43-60. DOI: 10.1017/S0959259812000160 |
0.01 |
|
| 2013 |
Fan Z, Edison P. P3–131: Influence of amyloid deposition on cerebral glucose metabolism in mild cognitive impairment subjects Alzheimer's & Dementia. 9. DOI: 10.1016/j.jalz.2013.05.1202 |
0.01 |
|
| 2012 |
Corbett A, Pickett J, Burns A, Corcoran J, Dunnett SB, Edison P, Hagan JJ, Holmes C, Jones E, Katona C, Kearns I, Kehoe P, Mudher A, Passmore A, Shepherd N, et al. Drug repositioning for Alzheimer's disease. Nature Reviews. Drug Discovery. 11: 833-46. PMID 23123941 DOI: 10.1038/Nrd3869 |
0.01 |
|
| 2012 |
Edison P, Hinz R, Ramlackhansingh AF, Thomas J, Gelosa G, Archer HA, Turkheimer FE, Brooks DJ. Can target-to-pons ratio be used as a reliable method for the analysis of [ 11C]PIB brain scans? Neuroimage. 60: 1716-1723. PMID 22306804 DOI: 10.1016/J.Neuroimage.2012.01.099 |
0.01 |
|
| 2012 |
Hyare H, Ramlackhansingh A, Gelosa G, Edison P, Rudge P, Brandner S, Brooks DJ, Collinge J, Mead S. 11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 340-1. PMID 21478204 DOI: 10.1136/Jnnp.2010.233692 |
0.01 |
|
| 2011 |
McMurdo ME, Roberts H, Parker S, Wyatt N, May H, Goodman C, Jackson S, Gladman J, O'Mahony S, Ali K, Dickinson E, Edison P, Dyer C. Improving recruitment of older people to research through good practice. Age and Ageing. 40: 659-65. PMID 21911335 DOI: 10.1093/ageing/afr115 |
0.01 |
|
| 2011 |
Edison P, Hinz R, Brooks DJ. Technical aspects of amyloid imaging for Alzheimer's disease. Alzheimer's Research & Therapy. 3: 25. PMID 21888692 DOI: 10.1186/Alzrt87 |
0.01 |
|
| 2011 |
Knight WD, Okello AA, Ryan NS, Turkheimer FE, RodrÃguez Martinez de Llano S, Edison P, Douglas J, Fox NC, Brooks DJ, Rossor MN. Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain : a Journal of Neurology. 134: 293-300. PMID 21084313 DOI: 10.1093/Brain/Awq310 |
0.01 |
|
| 2011 |
Edison P, Brooks D, Rinne J, Perry R, Gelosa G, Martinez de Liano SR. O1-06-08: Amyloid imaging in atypical dementia using 11C-PIB PET Alzheimer's & Dementia. 7: S108-S109. DOI: 10.1016/J.Jalz.2011.05.271 |
0.01 |
|
| 2010 |
Rodda J, Okello A, Edison P, Dannhauser T, Brooks DJ, Walker Z. 11C-PIB PET in subjective cognitive impairment European Psychiatry. 25: 123-125. PMID 19926266 DOI: 10.1016/J.Eurpsy.2009.07.011 |
0.01 |
|
| 2010 |
Edison P. MEDICAL MANAGEMENT OF ADULTS WITH NEUROLOGIC DISABILITIES Neurology. 74: 1750-1750. DOI: 10.1212/WNL.0B013E3181E043B7 |
0.01 |
|
| 2009 |
Edison P, Brooks DJ, Turkheimer FE, Archer HA, Hinz R. Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility. Neuroimage. 48: 329-38. PMID 19591948 DOI: 10.1016/J.Neuroimage.2009.06.079 |
0.01 |
|
| 2009 |
Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, NÃ¥gren K, Bullock R, Walker Z, Kennedy A, Fox NC, Rossor MN, Rinne JO, Brooks DJ. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology. 73: 754-60. PMID 19587325 DOI: 10.1212/Wnl.0B013E3181B23564 |
0.01 |
|
| 2009 |
Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy JC, Bullock R, Walker Z, Kennedy A, Fox NCI, Rossor M, Brooks DJ. Microglial activation and amyloid deposition in mild cognitive impairment A PET study Neurology. 72: 56-62. PMID 19122031 DOI: 10.1212/01.Wnl.0000338622.27876.0D |
0.01 |
|
| 2009 |
Edison P. Imaging cerebral amyloid in vivo Journal of the Neurological Sciences. 283: 263. DOI: 10.1016/j.jns.2009.02.097 |
0.01 |
|
| 2008 |
Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, Hammers A, Tai YF, Fox N, Kennedy A, Rossor M, Brooks DJ. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiology of Disease. 32: 412-9. PMID 18786637 DOI: 10.1016/J.Nbd.2008.08.001 |
0.01 |
|
| 2008 |
Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N, Villemagne VL, O'Keefe G, NÃ¥gren K, Chaudhury KR, Masters CL, Brooks DJ. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 1331-8. PMID 18653550 DOI: 10.1136/Jnnp.2007.127878 |
0.01 |
|
| 2008 |
Tomasi G, Edison P, Bertoldo A, Roncaroli F, Singh P, Gerhard A, Cobelli C, Brooks DJ, Turkheimer FE. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1249-56. PMID 18632810 DOI: 10.2967/Jnumed.108.050583 |
0.01 |
|
| 2008 |
Swingland JT, Edison P, Bose SK, Okello A, Brooks DJ, Turkheimer F. Disentangling functional imaging end-points in Alzheimer's disease Neuroimage. 41. DOI: 10.1016/J.Neuroimage.2008.04.085 |
0.01 |
|
| 2007 |
Anderson AN, Pavese N, Edison P, Tai YF, Hammers A, Gerhard A, Brooks DJ, Turkheimer FE. A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195. Neuroimage. 36: 28-37. PMID 17398120 DOI: 10.1016/J.Neuroimage.2007.02.017 |
0.01 |
|
| 2007 |
Turkheimer FE, Edison P, Pavese N, Roncaroli F, Anderson AN, Hammers A, Gerhard A, Hinz R, Tai YF, Brooks DJ. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 158-67. PMID 17204713 |
0.01 |
|
| 2007 |
Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 68: 501-8. PMID 17065593 DOI: 10.1212/01.Wnl.0000244749.20056.D4 |
0.01 |
|
| 2006 |
Archer HA, Edison P, Brooks DJ, Barnes J, Frost C, Yeatman T, Fox NC, Rossor MN. Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study. Annals of Neurology. 60: 145-7. PMID 16802294 DOI: 10.1002/Ana.20889 |
0.01 |
|
| 2006 |
Edison P, Rowe CC, Ahmed I, Villemagne VL, Rinne J, Brooks DJ. II.P13 Amyloid load in Parkinson's Disease Dementia (PDD) and Lewy Body Dementia (LBD) measured with 11C-PIB PET Parkinsonism & Related Disorders. 12: 28. DOI: 10.1016/S1353-8020(07)70092-5 |
0.01 |
|
| 2006 |
Turkheimer FE, Edison P, Pavese N, Roncaroli F, Hammers A, Gerhard A, Hinz R, Tai YF, Brooks DJ. Supervised reference region extraction for the quantification of [11C]-(R)-PK11195 brain studies Neuroimage. 31. DOI: 10.1016/J.Neuroimage.2006.04.009 |
0.01 |
|
| 2006 |
Fan Z, Dani M, Hinz R, Edison P. O5‐01‐02: VOXEL‐LEVEL INTERACTION BETWEEN NFT AND AMYLOID INFLUENCES/PREDICTS THE DECLINE RATE OF COGNITION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT Alzheimer's & Dementia. 14. DOI: 10.1016/j.jalz.2018.06.2996 |
0.01 |
|
| 2006 |
Femminella GD, Talib S, Harold D, Williams J, Edison P. O2-15-01: THE DIFFERENTIAL INFLUENCE OF IMMUNE, ENDOCYTOTIC AND LIPID METABOLISM GENES ON AMYLOID DEPOSITION AND NEURODEGENERATION IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P659-P659. DOI: 10.1016/j.jalz.2018.06.2724 |
0.01 |
|
| 2006 |
Okello A, Edison P, Archer H, Hinz R, Fox N, Rossor M, Brooks D. P2-120: Amyloid deposition and cerebral glucose metabolism in mild cognitive impairment : A longitudinal 11C-PIB and 18F-FDG PET study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.958 |
0.01 |
|
| 2006 |
Edison P, Okello A, Archer H, Hinz R, Fox N, Rossor M, Brooks DJ. O3-06-05 Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.236 |
0.01 |
|
| 2005 |
Edison P, Archer H, Hinz R, Hammers A, Gerhard A, Pavese N, Tai Y, Hotton G, Cuttler D, Fox N, Rossor M, Brooks DJ. Correlation of regional cerebral amyloid load in Alzheimer's disease, measured with [11C]-PIB PET using spectral analysis and tissue uptake ratios, with performance on recognition memory tests. Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0591 |
0.01 |
|
| 2005 |
Hinz R, Blomquist G, Edison P, Brooks DJ. Parametric imaging of [11C]PIB studies using spectral analysis. Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0590 |
0.01 |
|
| 2005 |
Edison P, Archer H, Hinz R, Gerhard A, Turkheimer F, Hammers A, Pavese N, Tai YF, Rossor M, Brooks DJ. Correlations between the distribution of microglial activation and amyloid plaque load in Alzheimer’s disease: An 11C-PK11195 and 11C-PIB PET study Alzheimers & Dementia. 1. DOI: 10.1016/J.Jalz.2005.06.298 |
0.01 |
|
| 2005 |
Edison P, Archer H, Hinz R, Gerhard A, Hammers A, Pavese N, Tai YF, Fox N, Rossor M, Brooks DJ. Amyloid load in mild cognitive impairment compared to Alzheimer patients and normal subjects: An 11C-PIB PET study Alzheimers & Dementia. 1. DOI: 10.1016/J.Jalz.2005.06.185 |
0.01 |
|
| 2005 |
Brooks D, Edison P, Archer H, Hinz R, Gerhard A, Hammers A, Pavese N, Tai Y, Cuttler D, Fox N, Rossor M, Brooks D. The relationship between amyloid load, microglial activation, and cognition in Alzheimer’s disease: PET findings Alzheimers & Dementia. 1. DOI: 10.1016/J.Jalz.2005.06.053 |
0.01 |
|
| 2002 |
Johansen A, Vasishta S, Edison P, Hosein I. Clostridium difficile associated diarrhoea: how good are nurses at identifying the disease? Age and Ageing. 31: 487-8. PMID 12446303 |
0.01 |
|
| Hide low-probability matches. |